Serious adverse outcomes are categorized according to FDA-defined criteria, including: mortality (DE), life-threatening conditions (LT), hospitalization (HO), disability (DS), congenital anomalies (CA), and other medically significant events (OT)
4-6wks Typical cycle duration with proper medical monitoring and planned rest periods 1x/day Once-daily subcutaneous injection due to extended half-life Questions IGF-1 LR3 features a 13-amino acid N-terminal extension that extends its half-life from minutes to 20-30 hours and reduces binding to IGF binding proteins
Once a pen has been opened or the tamper seal broken, it cannot be returned, standard practice for sterile research consumables
Any used glutathione is then recycled back into usable glutathione by your GSR enzyme
When CPT1C is upregulated, it increases FA consumption, and ATP production, facilitating tumor growth and survival 43